Mohr Davidow's Siegel tapped to run $6B GE health tech initiative

Mohr Davidow Ventures' Sue Siegel, the former president of Affymetrix ($AFFX), is leaving the venture group to take the reins at GE's $6 billion healthymagination project. An expert in tech platforms and molecular diagnostics, Siegel brings considerable experience in the personalized medicine field to the task. Mohr Davidow, Kleiner Perkins and other VC groups have been working with GE to identify new technologies that can cut healthcare costs by 2015. Release


Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.